BBVA
WST icon

Banco Bilbao Vizcaya Argentaria’s West Pharmaceutical WST Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$507K Sell
1,413
-689
-33% -$211K ﹤0.01% 620
2026
Q1 		$526K Sell
2,102
-3,881
-65% -$966K ﹤0.01% 627
2025
Q4 		$1.65M Buy
5,983
+4,042
+208% +$1.11M 0.01% 459
2025
Q3 		$509K Buy
1,941
+595
+44% +$145K ﹤0.01% 624
2025
Q2 		$294K Sell
1,346
-220
-14% -$47K ﹤0.01% 654
2025
Q1 		$351K Sell
1,566
-4,554
-74% -$1.26M ﹤0.01% 643
2024
Q4 		$2M Sell
6,120
-666
-10% -$210K 0.02% 407
2024
Q3 		$2.04M Sell
6,786
-2,884
-30% -$883K 0.02% 439
2024
Q2 		$3.21M Buy
9,670
+2,613
+37% +$923K 0.03% 349
2024
Q1 		$2.79M Sell
7,057
-3,402
-33% -$1.26M 0.03% 378
2023
Q4 		$3.68M Buy
10,459
+1,012
+11% +$358K 0.04% 326
2023
Q3 		$3.56M Buy
9,447
+42
+0.4% +$16.2K 0.05% 317
2023
Q2 		$3.59M Buy
9,405
+3,199
+52% +$1.14M 0.05% 322
2023
Q1 		$2.16M Buy
6,206
+1,614
+35% +$472K 0.03% 407
2022
Q4 		$1.08M Buy
4,592
+801
+21% +$190K 0.02% 483
2022
Q3 		$938K Buy
3,791
+1,027
+37% +$313K 0.02% 476
2022
Q2 		$836K Sell
2,764
-295
-10% -$96K 0.01% 490
2022
Q1 		$1.26M Sell
3,059
-9,590
-76% -$3.75M 0.02% 452
2021
Q4 		$5.96M Buy
12,649
+3,708
+41% +$1.6M 0.08% 218
2021
Q3 		$3.8M Buy
8,941
+526
+6% +$222K 0.06% 257
2021
Q2 		$3.02M Buy
8,415
+673
+9% +$222K 0.05% 299
2021
Q1 		$2.18M Buy
7,742
+1,010
+15% +$289K 0.04% 329
2020
Q4 		$1.91M Buy
6,732
+5,327
+379% +$1.49M 0.04% 343
2020
Q3 		$386K Buy
1,405
+143
+11% +$37.8K 0.01% 565
2020
Q2 		$286K Buy
+1,262
New +$248K 0.01% 636

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's WST Position: Q2 2026 in Review

Banco Bilbao Vizcaya Argentaria reduced its West Pharmaceutical (WST) stake by 33% in Q2 2026, selling an estimated $211K and leaving 1,413 shares worth $507K. The position accounts for ﹤0.01% of the portfolio, ranked #620.

Banco Bilbao Vizcaya Argentaria first reported a position in WST in Q2 2020 and has held it in 25 quarters since. The position peaked at $5.96M in Q4 2021. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Banco Bilbao Vizcaya Argentaria held 1,413 shares of West Pharmaceutical worth $507K as of Q2 2026.
  • Banco Bilbao Vizcaya Argentaria sold 689 West Pharmaceutical shares in Q2 2026, an estimated $211K.
  • West Pharmaceutical made up ﹤0.01% of Banco Bilbao Vizcaya Argentaria's portfolio in Q2 2026, its #620 holding.
  • Banco Bilbao Vizcaya Argentaria first reported a position in West Pharmaceutical in Q2 2020 and has held it in 25 quarters since.
  • Banco Bilbao Vizcaya Argentaria's West Pharmaceutical position peaked at $5.96M in Q4 2021.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q2 2026, filed 12 Aug 2026.